Researchers from the University of Minnesota Medical School and College of Pharmacy have found that high costs for hepatic encephalopathy treatment in patients with end-stage liver disease are associated with decreased treatment ...
Aug 24, 2023
0
15
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Nanyang ...
Jun 6, 2023
0
2
When most people think of cirrhosis, the first organ that comes to mind is the liver. However, hepatic encephalopathy can be described as a disorder caused by severe liver disease that impacts the nervous system, and ultimately, ...
Mar 30, 2022
0
5
For patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement, rifaximin used before and after the procedure is associated with a reduced risk for overt hepatic encephalopathy (HE), ...
Feb 2, 2021
0
4
(HealthDay)—About one-third of patients with inactive intestinal Behçet's disease (BD) have small intestinal bacterial overgrowth (SIBO), and rifaximin is associated with symptom improvement, according to a study published ...
Jul 13, 2017
0
1
Patients with inflammatory diseases are often prescribed non-steroidal anti-inflammatory drugs. They are also often prescribed a proton pump inhibitor to protect their stomach. In a joint study, clinical pharmacologist Markus ...
Apr 11, 2017
0
161
